Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.74+0.01 (+0.07%)
Close on Nov 13, 2026Market cap $12.30BP/E 26.9Yield 0.58%
Dr Reddys Laboratories gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2026 it was 52.8%, against 58.5% the year before. The highest annual figure on record is 59.6% in fiscal 2016.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | 52.8% | −5.7 |
| FY2025 | Mar 31, 2025 | 58.5% | −0.1 |
| FY2024 | Mar 31, 2024 | 58.6% | +1.9 |
| FY2023 | Mar 31, 2023 | 56.7% | +3.6 |
| FY2022 | Mar 31, 2022 | 53.1% | −1.2 |
| FY2021 | Mar 31, 2021 | 54.3% | +0.5 |
| FY2020 | Mar 31, 2020 | 53.8% | −0.4 |
| FY2019 | Mar 31, 2019 | 54.2% | +0.5 |
| FY2018 | Mar 31, 2018 | 53.7% | −1.9 |
| FY2017 | Mar 31, 2017 | 55.6% | −4.0 |
| FY2016 | Mar 31, 2016 | 59.6% | – |
See a number that looks wrong?